Back to EPRX
INGALLS & SNYDER LLC EPRX Position History
Eupraxia Pharmaceuticals Inc. • Healthcare
Quarters held
4
Latest value
$687K
Q3 2026
Peak value
$687K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $584K |
| Q1 2026 | $548K |
| Q2 2026 | $452K |
| Q3 2026 | $687K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $687K | 75.5K | — | — |
| Q2 2026 | $452K | 68.5K | — | — |
| Q1 2026 | $548K | 75.7K | — | — |
| Q4 2025 | $584K | 77.4K | — | — |